Results 221 to 230 of about 33,669,679 (309)

Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin

open access: yesMolecular Oncology, EarlyView.
Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon   +4 more
wiley   +1 more source

Exosomal MicroRNAs as theranostic tools in type 2 diabetes and its complications: mechanistic insights and clinical implications. [PDF]

open access: yesDiabetol Metab Syndr
Vukelić I   +9 more
europepmc   +1 more source

Interrupting sedentary behaviour in the workplace through active breaks: a protocol study. [PDF]

open access: yesBMJ Open Sport Exerc Med
Scoppolini Massini M   +6 more
europepmc   +1 more source

ChatGPT in liver transplantation: Current applications, limitations, and future directions. [PDF]

open access: yesWorld J Transplant
Avramidou E   +5 more
europepmc   +1 more source

Antimicrobial Resistance: The Answers. [PDF]

open access: yesBr J Biomed Sci
Millar BC   +6 more
europepmc   +1 more source

Tiny plastic, big trouble: how polystyrene nanoparticles impact DNA-damage repair deficient cervical cancer cells.

open access: yesSoft Matter
Berezowitz JD   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy